Specialty Overview

Best Hospitals for Blood Cancer Treatment in Delhi NCR, India

35 cancer care hospitals in our India network are listed in Delhi NCR, accredited by JCI, NABH, NABL, ISO, with 17,362 beds combined.

35
Hospitals Listed
1
City
4.5
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the cancer care hospitals in our directory offering Blood Cancer Treatment in Delhi NCR, India, including Apollo Hospitals, Medanta - The Medicity, Artemis Hospital, Fortis Memorial Research Institute and others. Each listing links through to the hospital's full profile page.

Ask us about blood cancer treatment in Delhi NCR, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 35 accredited hospitals for Cancer Care in Delhi NCR, India

Starting from$1,000

🇮🇳 Apollo Hospitals

New Delhi, India 4.9 (1240 reviews) 1,000 beds
Why consider this hospital?
4.9/5 rating from 1240 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering blood cancer treatment can be cared for by Apollo Hospitals's care team in New Delhi, India, from initial consultation through recovery. Apollo Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing blood cancer treatment.

4.9/5
Rating
1983
Established
1,000
Beds
New Delhi, India
Location
Medanta - The Medicity
Starting from$1,000

🇮🇳 Medanta - The Medicity

Gurgaon, India 4.9 (2150 reviews) 1,600 beds
Why consider this hospital?
4.9/5 rating from 2150 reviewsAccredited by JCI, NABH1,600 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering blood cancer treatment can be cared for by Medanta - The Medicity's care team in Gurgaon, India, from initial consultation through recovery. Medanta - The Medicity, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing blood cancer treatment.

4.9/5
Rating
2009
Established
1,600
Beds
Gurgaon, India
Location
Artemis Hospital
Starting from$1,000

🇮🇳 Artemis Hospital

Gurgaon, India 4.9 (64 reviews) 750 beds
Why consider this hospital?
4.9/5 rating from 64 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering blood cancer treatment can be cared for by Artemis Hospital's care team in Gurgaon, India, from initial consultation through recovery. Artemis Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing blood cancer treatment.

4.9/5
Rating
2007
Established
750
Beds
Gurgaon, India
Location
Fortis Memorial Research Institute
Starting from$1,000

🇮🇳 Fortis Memorial Research Institute

Gurgaon, India 4.8 (1100 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1100 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering blood cancer treatment can be cared for by Fortis Memorial Research Institute's care team in Gurgaon, India, from initial consultation through recovery. Fortis Memorial Research Institute, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing blood cancer treatment.

4.8/5
Rating
1996
Established
1,000
Beds
Gurgaon, India
Location
Max Super Specialty Hospital
Starting from$1,000

🇮🇳 Max Super Specialty Hospital

New Delhi, India 4.8 (1300 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 1300 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
CardiacLiver Transplant
Accredited by JCI, NABH

Patients considering blood cancer treatment can be cared for by Max Super Specialty Hospital's care team in New Delhi, India, from initial consultation through recovery. Max Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing blood cancer treatment.

4.8/5
Rating
2000
Established
500
Beds
New Delhi, India
Location
All India Institute of Medical Sciences (AIIMS)
Starting from$1,000

🇮🇳 All India Institute of Medical Sciences (AIIMS)

New Delhi, India 4.7 (3500 reviews) 2,400 beds
Why consider this hospital?
4.7/5 rating from 3500 reviewsAccredited by NABH2,400 beds
Specialties & Accreditation
Multi-specialtyResearch
Accredited by NABH

Patients considering blood cancer treatment can be cared for by All India Institute of Medical Sciences (AIIMS)'s care team in New Delhi, India, from initial consultation through recovery. All India Institute of Medical Sciences (AIIMS), accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing blood cancer treatment.

4.7/5
Rating
1956
Established
2,400
Beds
New Delhi, India
Location
CK Birla Hospital
Starting from$1,000

🇮🇳 CK Birla Hospital

Gurugram, Haryana, India 4.7 (162 reviews) 90 beds
Why consider this hospital?
4.7/5 rating from 162 reviewsAccredited by NABH90 beds
Specialties & Accreditation
Obstetrics & GynecologyOrthopedicsCardiac SciencesOncologyPediatrics
Accredited by NABH

Patients considering blood cancer treatment can be cared for by CK Birla Hospital's care team in Gurugram, Haryana, India, from initial consultation through recovery. CK Birla Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing blood cancer treatment.

4.7/5
Rating
2017
Established
90
Beds
Gurugram, Haryana, India
Location
Centre for Sight
Starting from$1,000

🇮🇳 Centre for Sight

Safdarjung Enclave, New Delhi, India 4.7 (181 reviews) 30 beds
Why consider this hospital?
4.7/5 rating from 181 reviewsAccredited by NABH30 beds
Specialties & Accreditation
LASIK SurgeryRetina SurgeryCataract SurgeryGlaucomaCornea Transplant
Accredited by NABH

Patients considering blood cancer treatment can be cared for by Centre for Sight's care team in Safdarjung Enclave, New Delhi, India, from initial consultation through recovery. Centre for Sight, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing blood cancer treatment.

4.7/5
Rating
1996
Established
30
Beds
Safdarjung Enclave, New Delhi, India
Location
Max Super Specialty Hospital, Gurgaon
Starting from$1,000

🇮🇳 Max Super Specialty Hospital, Gurgaon

Gurgaon, India 4.6 (95 reviews) 104 beds
Why consider this hospital?
4.6/5 rating from 95 reviewsAccredited by NABH, JCI104 beds
Specialties & Accreditation
Cardiac SciencesOncologyOrthopedicsNeurosciencesTransplant
Accredited by NABH, JCI

Patients considering blood cancer treatment can be cared for by Max Super Specialty Hospital, Gurgaon's care team in Gurgaon, India, from initial consultation through recovery. Max Super Specialty Hospital, Gurgaon, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing blood cancer treatment.

4.6/5
Rating
2007
Established
104
Beds
Gurgaon, India
Location
Max Super Speciality Hospital, Patparganj
Starting from$1,000

🇮🇳 Max Super Speciality Hospital, Patparganj

Patparganj, New Delhi, India 4.6 (97 reviews) 400 beds
Why consider this hospital?
4.6/5 rating from 97 reviewsAccredited by NABH, JCI400 beds
Specialties & Accreditation
Cardiac SciencesOncologyOrthopedicsNeurosciencesTransplant
Accredited by NABH, JCI

Patients considering blood cancer treatment can be cared for by Max Super Speciality Hospital, Patparganj's care team in Patparganj, New Delhi, India, from initial consultation through recovery. Max Super Speciality Hospital, Patparganj, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing blood cancer treatment.

4.6/5
Rating
2005
Established
400
Beds
Patparganj, New Delhi, India
Location
Our Methodology

How we selected these hospitals

A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Delhi NCR, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Blood Cancer Treatment in Delhi NCR, India?

Choosing the right hospital for blood cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include cancer care rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Blood Cancer Treatment

Blood cancer — encompassing leukemia, lymphoma, and multiple myeloma — requires highly specialized, protocol-driven oncology care that combines chemotherapy, targeted biologics, immunotherapy, and, when indicated, hematopoietic stem cell transplantation (HSCT).

14–42 days (varies by protocol: induction chemotherapy, transplant conditioning, or CAR-T cell infusion cycles)
Hospital Stay
6–16 weeks (depending on treatment modality; stem cell transplant patients require a minimum of 90 days in-country post-engraftment before international travel is medically cleared)
Total Stay in Country (Fit-to-Fly)
60–88% (5-year overall survival; subtype- and stage-dependent — ALL in children: ~88%; DLBCL with R-CHOP: ~65–70%; AML complete remission after induction: ~60–80%; Multiple Myeloma progression-free survival at 5 years with novel agents: ~50–60%)
Success Rate

Clinical Overview

  • Blood cancers arise from the uncontrolled proliferation of malignant hematopoietic cells within the bone marrow, lymphatic system, or peripheral blood.
  • The three principal categories — leukemia (acute and chronic), lymphoma (Hodgkin and Non-Hodgkin), and multiple myeloma (a plasma cell dyscrasia) — each disrupt normal blood cell production in distinct ways.
  • In leukemia, blasts crowd the marrow, impairing erythropoiesis and thrombopoiesis, leading to anemia, hemorrhagic risk, and severe immunosuppression.
Full details →

Who is a Candidate?

  • ELIGIBILITY — DIAGNOSIS-CONFIRMED CASES: Patients with histopathologically confirmed blood cancer (bone marrow biopsy, lymph node biopsy, or trephine biopsy) who require induction chemotherapy, consolidation, maintenance therapy, or hematopoietic stem cell transplantation (autologous or allogeneic HSCT).
  • NEWLY DIAGNOSED PATIENTS: Those in need of frontline protocol initiation — including pediatric and adult ALL, AML, CML in chronic/accelerated phase, Hodgkin lymphoma, aggressive and indolent NHL, and newly diagnosed multiple myeloma.
  • RELAPSED OR REFRACTORY DISEASE: Patients who have failed one or more prior lines of therapy and require salvage regimens (e.g., R-ICE, R-DHAP, ESHAP for lymphoma; azacitidine or venetoclax-based combinations for AML) or access to CAR-T cell therapy (axicabtagene ciloleucel, tisagenlecleucel) or bispecific T-cell engager therapy.
  • STEM CELL TRANSPLANT CANDIDATES: Patients with AML, ALL, CML, MDS, or chemosensitive relapsed lymphoma eligible for myeloablative or reduced-intensity conditioning (RIC) allogeneic HSCT, or autologous HSCT for myeloma and relapsed Hodgkin/NHL.
  • +2 more

Treatment Options & Approaches

  • CHEMOTHERAPY PROTOCOLS (STANDARD OF CARE)

Recovery

  • PHASE 1 — PRE-ARRIVAL & REMOTE CONSULTATION (WEEKS 1–2)

Risks to be aware of

  • Blood cancer treatment carries substantial, protocol-specific risks that must be thoroughly understood before initiating therapy.
  • Induction chemotherapy for AML or ALL induces prolonged profound pancytopenia (absolute neutrophil count <100/μL for 2–4 weeks), creating a critical window for life-threatening infections — bacteremia, invasive fungal infections (Aspergillus, Candida), and viral reactivation (CMV, EBV, VZV).
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive end-to-end non-medical coordination for international blood cancer patients traveling to India or the UAE, recognizing that oncology patients require a higher standard of logistical support than routine medical tourists.

Cost Range for Related Procedures

Cancer Surgery$4,000$15,000
Chemotherapy$1,000$4,000
Radiation Therapy$3,500$10,000
Get a personalised estimate with our cost calculator →

Common questions about Blood Cancer Treatment

What is the cost of blood cancer treatment in India vs the UAE?
The cost of blood cancer treatment varies significantly based on the type of cancer (leukemia, lymphoma, or multiple myeloma), the treatment protocol required, and whether hematopoietic stem cell transplantation (HSCT) or CAR-T cell therapy is involved. In India, at JCI- or NABH-accredited cancer centers, the total cost for a comprehensive treatment course — including chemotherapy induction cycles, diagnostics (NGS, PET-CT, bone marrow studies), and autologous or allogeneic stem cell transplantation — typically ranges from USD 7,000 to USD 55,000. A single chemotherapy induction course (e.g., 7+3 for AML or R-CHOP for DLBCL) ranges from USD 7,000–15,000, while allogeneic HSCT from a matched unrelated donor (MUD) ranges from USD 30,000–55,000. In the UAE, at JCI-accredited and DHA-licensed oncology centers in Dubai and Abu Dhabi, equivalent treatment costs range from USD 18,000 to USD 120,000, with allogeneic HSCT in the range of USD 70,000–120,000. India is typically 40–60% less expensive than the UAE for equivalent oncology protocols using the same WHO-approved drug regimens and international-standard diagnostics. GAF Healthcare provides fully transparent, itemized cost estimates inclusive of hospital stay, chemotherapy drugs, supportive medications, and monitoring investigations before any commitment is made.
How long do I need to stay in the country before I am fit to fly home after blood cancer treatment?
The required in-country stay before international air travel is medically safe is highly dependent on the treatment modality. For patients receiving outpatient or short-stay chemotherapy cycles (e.g., CML patients on oral TKI therapy, or patients completing a single R-CHOP cycle for lymphoma), a minimum in-country stay of 3–4 weeks per cycle is recommended to allow for CBC recovery assessment, response evaluation, and management of any immediate toxicity. For patients undergoing autologous HSCT (common for multiple myeloma and relapsed Hodgkin/NHL), the minimum safe in-country stay is 6–8 weeks from the date of stem cell reinfusion (Day 0), once ANC engraftment is confirmed, no active infections are present, and the patient can independently manage oral medications. For patients undergoing allogeneic HSCT (matched sibling, MUD, or haploidentical donor transplant), international air travel is not medically cleared until a minimum of 90 days post-transplant, as this window is critical for GvHD surveillance, chimerism monitoring, immune reconstitution assessment, and infectious complication management. Patients who develop acute GvHD, viral reactivation (CMV, EBV), or delayed engraftment may require an extended stay of 4–5 months. GAF Healthcare works closely with the transplant physician team to provide patients with a formal fit-to-fly certificate, coordinate extended visa arrangements as needed, and arrange continuity of care documentation for the patient's home oncologist.
What is the success rate of blood cancer treatment at hospitals in India and the UAE?
Success rates in blood cancer treatment vary considerably by diagnosis, disease stage, patient age, and molecular risk stratification, and the figures reported at JCI-accredited centers in India and the UAE are consistent with international benchmarks published by the NMDP, EBMT, and SEER. For Acute Lymphoblastic Leukemia (ALL) in children, complete remission rates exceed 95% with modern multi-agent protocols (BFM or COG-based), with 5-year event-free survival of approximately 85–90%. For adult ALL, 5-year overall survival ranges from 40–60%, improving significantly in BCR-ABL1-positive ALL with the addition of TKI therapy and CAR-T in the relapsed setting. For Acute Myeloid Leukemia (AML), induction remission is achieved in 60–80% of younger patients; 5-year overall survival with allogeneic HSCT in favorable-risk AML approaches 60–70%. For Diffuse Large B-Cell Lymphoma (DLBCL), first-line R-CHOP produces a 5-year overall survival of approximately 60–70%; patients achieving complete metabolic response (PET-negative) at end-of-treatment have outcomes exceeding 75%. For Hodgkin Lymphoma (early-stage), cure rates with ABVD or BV-AVD exceed 85–90%. For Multiple Myeloma, while not considered curable with current standard therapy, modern quadruplet induction followed by autologous HSCT and lenalidomide maintenance achieves a median progression-free survival of 5–7 years in transplant-eligible patients, with some patients achieving 10+ year remissions. For CML, treatment with second-generation TKIs achieves major molecular response (MMR) in over 80% of patients at 12 months, with near-normal life expectancy in optimal responders. GAF Healthcare facilitates treatment at high-volume centers where these outcomes are consistently achieved and where multidisciplinary tumor boards, molecular diagnostics, and advanced cellular therapy capabilities are all available under one roof.

How GAF Healthcare Assists in Choosing the Best Hospital for Blood Cancer Treatment in Delhi NCR, India

Discover the Top Hospitals for Blood Cancer Treatment in Delhi NCR, India

This page lists 35 accredited cancer care hospitals in Delhi NCR, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about blood cancer treatment in Delhi NCR, India

How many cancer care hospitals are listed in Delhi NCR, India?
35 hospitals in our Delhi NCR, India directory are currently listed for cancer care including Blood Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Delhi NCR, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there cancer care hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL, ISO — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for blood cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about blood cancer treatment in Delhi NCR, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for blood cancer treatment in Delhi NCR, India.

Contact us to report an inaccuracy on this page.